Antiseptic TFM performance criteria too stringent, industry rep tells FDA advisory cmte.
This article was originally published in The Tan Sheet
ANTISEPTIC TFM PERFORMANCE CRITERIA TOO STRINGENT, INDUSTRY REP claims at FDA's Nonprescription Drugs Advisory Committee meeting in Bethesda, Md. July 29. Rhonda Jones, Scientific & Regulatory Consultants, Inc., presented to the committee five examples of antiseptic formulations used in consumer and health care environments she said "fall short of the current performance criteria proposed" in FDA's 1994 health care antiseptic tentative final monograph. Two triclosan hand washes at 1% and .3% -- levels of the ingredient often found in consumer products -- do not meet TFM performance criteria, despite having "positive clinical outcomes" and the potential for "viral removal" in other studies, Jones said.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC